SGLT2 inhibition and cardiovascular outcomes: lessons from recent clinical trials
ESC HF 2016 Presentation prepared and held by David Fitchett MD, University of Toronto, Canada at the CME accredited 'Diabetes & Heart Failure: Evaluating novel strategies to address outcomes' held on May 21, 2016 in Florence, Italy.
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: